JNJ vs PFE
By Alex · Tickerpine
Johnson & Johnson vs Pfizer, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PFE |
|---|---|---|
| Price | $260.86 | $26.31 |
| Market cap | $628.65B | $149.96B |
| P/E ratio | 30.3 | 35.1 |
| ROE | 25.74% | 5.01% |
| Profit margin | 21.48% | 6.80% |
| Revenue growth | 6.60% | 2.60% |
| Dividend yield | 2.05% | 6.46% |
| Beta | 0.23 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PFE in plain English
- JNJ is the bigger company — about 4.2× the market cap of PFE.
- JNJ is cheaper on earnings (P/E 30.3 vs 35.1).
- JNJ earns a higher return on equity (26% vs 5%).
- JNJ is growing revenue faster (7% vs 3%).
- PFE has the higher dividend yield (6.46% vs 2.05%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PFE return calculator
See what $1,000 in Pfizer, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.